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Abstract
Similar patterns of cognitive and motor deficits have been widely reported from manganese 
exposures in welding, metallurgical and chemical industry workers. A risk assessment was 
performed based on studies reported in the literature, extending some earlier work, and deriving 
new estimates of exposure response and excess risk. Many investigations of manganese 
neurological effects in humans have insufficient information to derive an exposure response; 
however, findings from a chemical manufacturer, two smelter and two welder populations 
permitted application of the benchmark dose procedure for continuous end-points. Small particles 
and aggregates of condensation fume (condensing vaporized metal, <0.1 μm in diameter) appear to 
have a higher potency per unit mass than larger particles from dusts (>1.0 μm). Consideration was 
given to long-term effects of continuous low exposures that instead of producing increasing 
toxicity attain a steady-state condition. Impairment was defined as excursions beyond the 5th 
percentile in a normal population and the concentrations of manganese predicted to result in 1% 
excess prevalence of impairment over different time periods were calculated. Over five years, 
exposures resulting in 1% excess prevalence of impairment (for purposes of discussion) were in 
the vicinity of 10 μg/m3 for manganese fume and 25 μg/m3 for larger particle dusts. These levels 
are below current recommendations for occupational limits on manganese exposure in the United 
States.
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1. Introduction
Blood levels of manganese (Mn), an essential nutrient, are heavily regulated to 
accommodate widely varying food intake and interacting iron metabolism. The routine 
physiologic control of Mn is mostly exercised in the gastrointestinal tract and liver, while 
inhaled manganese appears to be much less well managed (Andersen et al., 1999). The 
metabolic control of Mn has been examined in detail using physiologically based 
pharmacokinetic (PBPK) models (Ramoju et al., 2017).
There is considerable epidemiological evidence of homeostatic Mn regulation. Quebec 
smelter workers showed a negative dose-rate effect where increasing air levels of Mn 
produced less than proportional increases in a) blood levels (Park et al., 2014a) and b) 
neurobehavioral effects (Park et al., 2014b). For the neurobehavioral end-points examined in 
Quebec smelter workers, such as those measured by the Luria Motor scale, recent duration 
of exposure (e.g., prior five years) was as good as, or superior to, the corresponding recent 
Mn cumulative exposure metric in predicting impairment using a detailed retrospective 
exposure assessment. In South African smelter workers, a strong attenuation of 
neurobehavioral effects with increasing cumulative Mn exposure suggests a role for 
homeostatic controls (Myers et al., 2003b; Thompson and Myers, 2006). While in humans 
there is a dose-response relationship with duration of exposure to airborne Mn at 
physiologically-regulated blood levels, lower exposure concentrations are also potentially 
hazardous. These considerations argue against a special role for short-term high exposures, 
although delays in physiological regulatory responses to rapidly changing exposure levels 
could become important in uptake and distribution.
In response to the growing large body of evidence concerning neurobehavioral impairment 
resulting from manganese occupational and ambient environmental inhalation exposures, 
several risk assessments have been conducted using epidemiologic data collected on welders 
and other Mn-exposed worker populations. Benchmark dose (BMD) analyses were applied 
using the Roels et al. (1992) data from alkaline battery workers and from a cohort of bridge 
welders (Bowler et al., 2006). Summaries of these risk assessments are presented here. In 
addition, studies of smelter workers in Quebec (Mergler et al., 1994) and South Africa 
(Myers et al., 2003b), and welding trainees (Laohaudomchok et al., 2011) provided 
additional opportunities for risk assessment. This work assembles risk estimates from the 
studies with sufficient retrospective exposure assessment and evaluation of neurobehavioral 
outcomes to support a quantitative risk assessment. Summary estimates of risk are presented 
along with discussion of issues unique to neurobehavioral end-points in protecting workers 
as previously raised by Park et al. (2006).
1.1. Benchmark dose calculations for risk assessment
BMD analyses require defining an impairment threshold for the outcome under study. This 
is often the 5th percentile of poor performance in a normal or unexposed population (used 
for the present analysis) or impairment quantified as a standardized or other evaluation score 
determined by clinical consensus. Also required is specification of a maximum acceptable 
increment in the attributable risk of impairment (Bailer et al., 1997; Crump, 1995), usually 
ranging from 0.1% to 10%. Considerations of homeostatic regulation imply that cumulative 
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exposure may not be an optimum metric in linear models of exposure response (Clewell et 
al., 2003; Park et al., 2014a, 2014b; Thompson and Myers, 2006). Other metrics related to 
body burdens of Mn have been used in estimating dose-response for neurobehavioral 
outcomes (Park et al., 2014a). In addition this risk assessment considers recent Mn 
exposures, defined as exposures in the prior 5 years, as a possible appropriate metric. 
However, most plausible metrics are correlated (e.g., cumulative exposure or burdens with 
various half-lives) and most population observations have been for relatively short time 
periods (compared to a 45 year working lifetime) making the choices of an appropriate 
metric and model specifications difficult for predicting long-term effects. One important 
possibility with some empirical support is that, for a given fixed low Mn exposure 
concentration, a steady-state or maximal response is attained after some time interval much 
less than 45 years. In the Quebec smelter study, there was weak support favoring burden 
metrics with half-lives on the order of a few years suggesting that impairment reflected 
relatively recent exposure, not cumulative exposure over a lifetime (Park et al., 2014b). The 
PBPK model simulation work of Ramoju et al. (2017) observed attainment of steady-state 
Mn concentrations in the globus pallidus after about 1 year at airborne concentrations of 300 
μg/m3 in battery manufacturing workers. In this situation, it would be inappropriate to 
linearly extrapolate an observed response based on cumulative exposure over several years 
to a 45 year working life. All of the risk assessments utilizing battery worker data reported 
by McClure and Odin (1998) used average current Mn exposure intensity as the predicting 
metric, implicitly assuming a steady state response, attained in this case over a 5 year period.
1.2. Published risk assessments
Lucchini et al. (1999) produced an estimate of the lowest observable adverse effect level 
(LOAEL) for Mn-induced neurobehavioral deficits in ferroalloy workers. The 97.7 μg/m3 
LOAEL was based on the mean cumulative exposure and mean duration (11.5 years) of the 
mid-level exposed subpopulation. This estimate was dependent on choices made in 
stratifying the population on exposure (Bailer et al., 1997; Clewell et al., 2003). It was also 
affected by the history of rapidly declining Mn air concentrations in this industry (2 to 5 fold 
reductions over 10 years), raising the possibility of irreversible effects sustained from earlier 
higher exposures. Roels et al. (1992) conducted a semi-quantitative risk assessment on their 
data of alkaline battery production workers and low-exposed chemical workers. They 
concluded that a lifetime integrated exposure of 1200 μg/m3-yr respirable Mn resulted in 
“slight neurofunctional changes in a significant proportion of exposed subjects.” In this 
study population with an average duration of exposure of 5.3 years, the lifetime integrated 
exposure level corresponded to an average level of 225 μg/m3.
McClure and Odin (1998) conducted a BMD analysis of, and summarized previous work on, 
the Roels et al. (1992) data on eye-hand coordination. The exposure metric used was a 
worker’s lifetime average air concentration of either total or respirable Mn. The average 
exposure levels for respirable Mn corresponding to maximum acceptable levels of increased 
risk of impairment were calculated making various exposure-response modeling 
assumptions (Table 1). There was considerable agreement across investigators and modeling 
approaches in estimating the benchmark dose for a 10% additive increase in risk of eye-hand 
coordination impairment above the 5th percentile threshold in relation to respirable Mn. The 
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estimates ranged from 113 to 183 μg/m3 (McClure and Odin, 1998). BMD estimates were 
also reported for additive excess risk levels of 5% down to 0.1% using three modeling 
strategies. Increased variability in risk estimates at the lower exposure concentrations was 
observed. For example, for a 0.5% risk increment in impaired eye-hand coordination, the 
BMDs ranged from 8 to 67 μg/m3.
Clewell et al. (2003) calculated BMDs across three neurobehavioral endpoints in the Roels 
et al. (1992) data: eye-hand coordination, visual reaction time and hand steadiness. 
Estimates of current exposures associated with 10% increments were 155, 400 and 520 
μg/m3, respectively, with an average BMD of 357 μg/m3. Clewell et al. (2003) also analyzed 
data from a low-exposed population of chemical manufacturing workers (Gibbs et al., 1999) 
across five endpoints using different modeling approaches for a total of 13 estimates based 
on current exposure. The BMD results for a 10% impairment increment ranged from 275 
μg/m3 (reaction time) to 3980 μg/m3 (tap time, continuous). Several of the outcomes were 
unable to be analyzed due to negative associations. The mean lower 95% confidence limit 
for the five endpoints (averaging models within endpoints) was 190 μg/m3, about the same 
as that calculated by Roels et al. (1992).
Park RM et al. (2006) conducted an exploratory risk assessment for neurobehavioral 
outcomes in welders working in confined spaces during construction of bridge piers 
originally reported by Bowler et al. (2007). Park et al. (2009) subsequently conducted a risk 
assessment of the same workers using more detailed work histories and a more complete 
exposure assessment (Table 2). Neurobehavioral assessment data were available for more 
than 80% of the welders employed for up to 2 years on this bridge construction project 
involving work in confined spaces. Exposures were estimated from compliance sampling 
including 116 mostly full-shift or half-shift personal breathing zone samples and 43 area 
samples. The bridge welders showed statistically significant negative performance 
associations with burden or cumulative burden metrics over a 2 year period in five of 10 
measures examined: Design Fluency (one-tailed p-value = 0.014, for exposure metric 
regression coefficient), Working Memory (WAIS III) (p = 0.015), Verbal IQ (p = 0.015), 
Verbal Comprehension (p = 0.016) and Stroop Color-Word (p = 0.045). The BMD estimates 
for a 5% increase in impairment ranged from 27 to 151 μg/m3 using the 1st, 5th and 10th 
percentile of normal to define impairment (Park et al., 2009) (Table 2). The deficits observed 
in these standardized neurobehavioral tests in bridge welders corresponded to significant 
levels of symptoms: 63% of welders had clinical depression on the Beck Depression 
Inventory (BDI), and 80% had clinical elevation in anxiety (Bowler et al., 2007).
2. Materials and methods
2.1. Description of published studies used for new assessments
From the Mergler et al. (1994) study of Quebec smelter workers three neurobehavioral end-
points (Luria Motor Scale, Trail Making A and Trail Making B) were used for BMD excess 
risk calculations [Table 3]. The original response data, as T-scores, were available and the 
exposure metrics used were those with the best statistical model fit in estimating the 
exposure response (Park et al., 2014b); these were burden metrics with half-lives based on 
estimated exposure levels of “small” respirable Mn. Applying the estimated exposure 
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response for a series of constant exposure levels over a 45 year working life using a 
benchmark dose procedure as described previously (Park et al., 2006) yielded corresponding 
risk estimates for the Luria Motor and Trail Making outcomes.
From the South African smelter workers study of Myers et al. (2003b) published regression 
model findings for both cognitive and motor outcomes in relation to cumulative Mn 
exposure provided a basis for risk assessment. The calculation of BMD estimates depended 
on normative data (expected means and standard deviations) for the reported outcomes 
which were provided by the study investigators [personal communication, Dr. Jonny Myers, 
10/16/16]. For several of the outcomes the investigators observed the exposure response to 
be non-linear with an initial rapid change at low levels of cumulative exposure (Myers et al., 
2003b; Thompson and Myers, 2006). The present risk assessment used the exposure 
response reported in the lowest cumulative exposure stratum (<1.3 mg/m3–yr) which is 
closer than the higher strata to worker exposure levels of concern. Applying the reported 
regression estimates of exposure response for the eight outcomes analyzed for the South 
African smelter workers in the benchmark dose procedure produced risk estimates for 45 
year exposures.
From the San Francisco bridge welders study, in addition to the five cognitive outcomes on 
which a published risk assessment was based (Park et al., 2009), eight other outcomes, all 
motor-related, were evaluated using regression results provided by the original investigators 
[personal communication, Drs. Vihra Gocheva and Rosemarie Bowler, 10/28/16] (Table 4). 
The regression analyses predicted motor outcomes in relation to cumulative Mn exposure 
(over the 2 year project), controlling for age, years of education and race, and corresponding 
risk estimates were calculated as previously performed for the five cognitive outcomes.
In a study of welding trainees from a Boston-area union (Laohaudomchok et al., 2011) 
response time, finger tapping, handwriting stability and Profile of Mood States (POMS) 
were evaluated. Response time was measured using the Continuous Performance Test [CPT, 
Neuro-behavioral Evaluation System 3; (Letz, 2000; Letz et al., 2003)]. Using linear 
regression those investigators found a significant increase in response time with welding 
exposure (β= 0.71 ms/(mg/m3-h), SEβ = 0.22). For the calculation of excess risk here, it was 
assumed that the CPT is approximately normally distributed in the general population and 
that the population standard deviation (SD) (unavailable) was close to that observed in the 
trainee group (e.g., 57 ms) although, in the latter, there could be additional variance due to 
the exposure effect. The population was exposed for only 1–5 years and excess risk was 
calculated for only a 15 year period rather than the usual working lifetime of 45 year 
because of the uncertainty on long-term cumulative effects (Table 4). The finger-tapping 
exposure-response regression result was very imprecise in this welder population with low 
exposures (median: 12.9 μg/m3 PM2.5 Mn) despite a statistically significant overall group 
performance deficit on finger tapping, and the handwriting and POMS outcomes posed 
challenges in terms of background rates, normal variability and defining impairment; these 
outcomes were not included in this risk assessment.
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2.2. Alternate risk assessment assumptions
Taking into account possible reversible components and attainment of steady-state levels of 
impairment with constant low exposure, the estimated fixed concentrations conferring 1% 
excess risk were calculated for the two smelter and the two welder populations 
corresponding to five rather than 45 years of exposure. For the chemical worker study, the 
exposure metric was average airborne concentration (not cumulative) and the duration of 
employment was about 5 years; therefore the reported risks were for the equivalent of 5-year 
cumulative exposures.
2.3. Data analysis
All calculations were performed in SAS (SAS, 1999) using macros constructed for specific 
benchmark dose estimations.
3. Results
From the Quebec smelter study, excess risks of 5% or 1% for the Luria Motor Scale 
corresponded to 45 year constant exposures of 21 or 5.5 μg/m3, respectively, for impairment 
defined as scores departing more than 1.64 SD from the mean (Table 3). The selected 
exposure metric used for Luria Motor Scale calculations assumed that the Mn blood burden 
had a half-life of 5 years and a linear dependence on exposure intensity that was truncated 
above 25 μg/m3(to address homeostasis); excess risk was evaluated at age 65 at which point 
the maximum burden would have occurred. The mean exposure averaged over time for this 
smelter population was 82 μg/m3 (Park et al., 2014a). For the Trail Making A and B 
outcomes, 1% excess risk over 45 years corresponded to Mn exposures of 2.5 and 7.0 μg/m3 
(Table 3). In the South African smelter study for an excess risk of 1%, the estimated 45 year 
exposures over eight outcomes ranged 4–12 μg/m3 inhalable Mn (Table 4). These estimates 
assumed that the exposure response observed in the low cumulative exposure stratum can be 
used to predict an accumulating risk over 45 years. For the motor outcomes in the bridge 
welder study, risks of 1% accruing from a 2 year period corresponded to Mn exposures 
ranging 13–89 μg/m3 (Table 4; discrepancy between Tables 2 and 4 for the outcomes 
reported in Park et al. (2009) arises because the SD used to define impairment in Table 2 
was derived from the regression residual standard error while in Table 4 the normative score 
SD was utilized). In the apprentice welders, increased response times (by 1.64 SD) with an 
excess risk of 1% corresponded to a 15 year exposure to 1.0 μg/m3 Mn (PM 2.5) (Tables 3 
and 4).
3.1. Five year steady-state risk assessment
For the Belgian battery chemical workers, whose average duration of exposure was about 5 
years, the 5-year risks corresponding to different levels of current exposure were those 
previously calculated (McClure and Odin, 1998). From the findings in the South African 
smelter study (Myers et al., 2003b) excess risks for cumulative exposures over 5 years were 
calculated in the same manner as for 45 years yielding substantially higher Mn levels for 1% 
excess risk (by a factor of 45/5) (Table 4). Similarly, estimates were calculated for the 
Quebec smelter workers, based on 5-year steady state exposures (Park et al., 2014b). For the 
San Francisco bridge welders, the estimates of exposure for 2-year (observed employment 
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duration on bridge piers at time of study) and 5-year effects were calculated based on 
reported cognitive outcome regression results (Park et al., 2009). For outcomes predicted by 
Mn burdens with small half-lives, e.g., the Design Fluency with 90 day half-life, the 
exposure levels causing a specified impairment over 2 or 5 years would be similar. For the 
bridge welder results on motor performance, the non-dominant hand findings were used 
because they were consistently stronger and displayed higher statistical significance. (The 
smaller effects in the dominant hand may represent a) neurological compensation or b) 
higher vulnerability of less used pathways in the brain [personal communication, Dr. Vihra 
Gocheva, 11/1/16]). Finally the 1% excess prevalence of impaired response time in 
apprentice welders (Laohaudomchok et al., 2011), calculated over 5 years gave an estimate 
of 2.9 μg/m3 Mn (Table 4).
Over 5 years, 1% excess risk of impairment appears to result from lower exposures to 
welding fume compared to the Belgian chemical and South African smelter exposures with 
larger airborne particulate (Table 4); in the South African smelter study, inhalable air 
sampling was conducted across homogeneous exposure zones covering raw material 
handling, electric furnace operation and crushing of cast manganese (Myers et al., 2003a). In 
the case of the Quebec smelter workers, the exposure metric used was “small respirable” 
particles derived from location proximity to electric furnace operation which produce a Mn 
fume with very small particle size. The 1% excess risk Mn concentrations for the Quebec 
smelter workers were similar to the welding populations. Although the dust-exposed 
workers, for which higher Mn concentrations were predicted for 1% excess risk, were 
evaluated primarily for motor-related effects, in the welding populations both motor and 
cognitive end-points appear to have similar responses, at lower concentrations.
4. Discussion
4.1. Reversibility and other concerns
In considering an exposure limit for occupational exposure to manganese, several issues 
must be addressed relating to neurobehavioral impairment: acceptable risk, metabolic 
regulation of this essential dietary nutrient, and the derivation of appropriate exposure-
response relationships. Neurobehavioral health effects that are adverse and measurable and 
would qualify as clinical impairment, such as depression, anxiety, memory loss or motor 
deficits, are appropriate end-points for consideration. Although the research literature 
provides clear evidence of adverse neurobehavioral effects of sustained low air Mn 
concentrations (<0.2 mg/m3), there are important unknowns such as a) the extent to which 
irreversible, cumulative changes are occurring, b) role of particle size, c) particle chemical 
form and solubility. Some apparent reversibility may actually be instances of complex 
compensation or accommodation imposing other burdens or adverse consequences (Martinu 
and Monchi, 2013; Mohr et al., 2016). Several investigations have examined aspects of 
reversibility (Bouchard et al., 2007a, 2007b, 2008; Bowler et al., 2011; Huang et al., 1998; 
Josephs et al., 2005). Some reversibility was observed by Bouchard et al. (2007a) in all three 
areas: neuromotor, cognitive and psychiatric outcomes. Reversibility, here, pertains to 
behavioral manifestations and may not reflect reversal of underlying neurological damage. 
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One issue is how workers should be protected from exposures resulting in reversible 
impairment, when experienced over periods less than a working lifetime.
This risk assessment examines end-points that could be interpreted as assessing both acute 
and chronic effects. No attempt was made to distinguish these, and the 5 year attainment 
period utilized tends to capture both acute and chronic contributions.
Risk assessment ultimately requires choosing a target excess risk. For illustration purposes, a 
target risk of 1% was selected. The risk assessments for multiple neurobehavioral end-points 
are summarized in Table 4, presenting the reported or calculated cumulative effects of Mn 
exposure and equivalent estimates based on 5 year steady-state responses. These estimates of 
airborne Mn exposure concentrations represent levels at which a 1% excess risk of 
impairment is expected where impairment is defined on the 5th percentile in the normal 
population or at 1.64 SD from normal. If there were irreversible and cumulative effects from 
Mn exposure, then the estimated steady state related exposures in Table 4 would represent 
upper bounds for the maximum allowable exposure. If there are only reversible effects and a 
steady-state is attained after 2 years, for example, then higher corresponding Mn levels 
would result, as displayed for the San Francisco bridge welders (Table 4).
4.2. Implications for risk management
For end-points evaluated in relation to small respirable Mn particulate, as for condensation 
fume, the exposure levels predicting 1% excess impairment ranged 2.9–35 μg/m3, and all but 
one were less than 17 μg/m3. For end-points evaluated for large Mn particulate, as in dusts, 
the exposure levels predicting 1% excess impairment ranged 16–106 μg/m3 (as both 
respirable and inhalable particulate), and all but one were greater than 30 μg/m3. Thus 
respirable exposures associated with 1% excess risk of adverse neurobehavioral effects 
correspond to concentrations of approximately 10 μg/m3 for Mn fume exposure (welding 
and electric furnace operations), and 25 μg/m3 for Mn dust (without fume, all other 
operations generating airborne Mn particulate). A somewhat higher level for larger 
particulate, e.g., 30–40 μg/m3, would correspond to inhalable Mn (as reported in Myers et 
al., 2003b).
For Mn fume this is a factor of 2.0 lower than the threshold limit value (TLV) presented by 
the American Conference of Governmental Industrial Hygienists (ACGIH) (ACGIH, 2013) 
for “respirable particulate matter.” Also specifying a two-tier occupational exposure limit, 
the ACGIH established a maximum level of 100 μg/m3 for “inhalable particulate matter” 
which would include dusts above the 10 μm range, from non-welding and non-electric 
furnace operations, and which is a factor of 4 higher than the 1% excess risk dust levels 
shown here (a factor of 3 for inhalable Mn). At other target excess risks, e.g., 5% or 0.5%, 
the corresponding Mn exposures would be essentially proportional to the 1% risk estimates.
4.3. Summary
This risk assessment utilized estimates of exposure response derived from epidemiological 
analyses of occupationally manganese-exposed populations. It extended some earlier work 
while calculating new estimates of exposure response and excess prevalence of impairment. 
Impairment was defined as excursions beyond the 5th percentile in a normal population. 
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Small particles and aggregates of condensation fume (condensing vaporized metal, <0.1 μm 
in diameter) appeared to have a higher potency per unit mass than larger particles from dusts 
(>1.0 μm) providing further support for a two-tiered approach previously adopted by 
ACGIH for establishing exposure limits to protect against adverse neurobehavioral effects. 
In considering an exposure limit, several issues were addressed relating to neurobehavioral 
impairment: acceptable risk, metabolic regulation of this essential dietary nutrient, and the 
derivation of appropriate exposure-response relationships for health effects that may be 
partially reversible, may attain maximal levels after prolonged exposures at moderate 
concentrations, and are responsive to homeostatic regulation. Although future investigations 
will enhance understanding of the mechanisms of Mn induced neurobehavioral effects, the 
currently available knowledge is sufficient for progress in risk assessment of public health 
significance.
Acknowledgments
Helpful comments were provided by Harvey J. Clewell III, Robert Dick, Donald Eggerth, and Sudha Pandalai. 
Supplemental data and findings were provided by Jonny Myers, Donna Mergler, and Vihra Gocheva and Rosemarie 
Bowler.
References
ACGIH. TLV Documentation Manganese, elemental and inorganic compounds Cincinnati. American 
Conference of Governmental Industrial Hygienists; OH: Signature Publications; 2013. 
Andersen ME, Gearhart JM, Clewell HJI. Pharmacokinetic data needs to support risk assessments for 
inhaled and ingested manganese. Neurotoxicology. 1999; 20:161–171. [PubMed: 10385880] 
Bailer AJ, Stayner LT, Smith RJ, Kuempel ED, Prince MM. Estimating benchmark concentrations and 
other noncancer endpoints in epidemiology studies. Risk Anal. 1997; 17:771–780. [PubMed: 
9463931] 
Bouchard M, Mergler D, Baldwin M, Panisset M, Bowler R, Roels HA. Neurobehavioral functioning 
after cessation of manganese exposure: a follow-up after 14 years. Am J Ind Med. 2007a; 50:831–
840. [PubMed: 17096374] 
Bouchard M, Mergler D, Baldwin M, Panisset M, Roels HA. Neuropsychiatric symptoms and past 
manganese exposure in a ferro-alloy plant. Neurotoxicology. 2007b; 28:290–297. [PubMed: 
16962176] 
Bouchard M, Mergler D, Baldwin ME, Panisset M. Manganese cumulative exposure and symptoms: a 
follow-up study of alloy workers. Neurotoxicology. 2008; 29:577–583. [PubMed: 18562007] 
Bowler RM, Gysens S, Diamond E, Nakagawa S, Drezgic M, Roels HA. Manganese exposure: 
neuropsychological and neurological symptoms and effects in welders. Neurotoxicology. 2006; 
27:315–326. [PubMed: 16343629] 
Bowler RM, Roels HA, Nakagawa S, Drezgic M, Diamond E, Park R, et al. Dose-effect relationships 
between manganese exposure and neurological, neuropsychological and pulmonary function in 
confined space bridge welders. Occup Environ Med. 2007; 64:167–177. [PubMed: 17018581] 
Bowler RM, Gocheva V, Harris M, Ngo L, Abdelouahab N, Wilkinson J, et al. Prospective study on 
neurotoxic effects in manganese-exposed bridge construction welders. Neurotoxicology. 2011; 
32:596–605. [PubMed: 21762725] 
Clewell HJ, Lawrence GA, Calne DB, Crump KS. Determination of an occupational exposure 
guideline for manganese using the benchmark method. Risk Anal. 2003; 23:1031–1046. [PubMed: 
12969417] 
Crump KS. Calculation of benchmark doses from continuous data. Risk Anal. 1995; 15:79–89.
Gibbs JP, Crump KS, Houck DP, Warren PA, Mosley WS. Focused medical surveillance: a search for 
subclinical movement disorders in a cohort of U: S. workers exposed to low levels of manganese 
dust. Neurotoxicology. 1999; 20:299–313. [PubMed: 10385892] 
Park and Berg Page 9
Neurotoxicology. Author manuscript; available in PMC 2018 April 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Huang CC, Chu NS, Lu CS, Chen RS, Calne DB. Long-term progression in chronic manganism: ten 
years of follow-up. Neurology. 1998; 50:698–700. [PubMed: 9521259] 
Josephs KA, Ahlskog JE, Klos KJ, Kumar N, Fealey RD, Trenerry MR, et al. Neurologic 
manifestations in welders with pallidal MRI T1 hyperintensity. Neurology. 2005; 64:2033–2039. 
[PubMed: 15888601] 
Laohaudomchok W, Lin X, Herrick RF, Fang SC, Cavallari JM, Shrairman R, et al. 
Neuropsychological effects of low-level manganese exposure in welders. Neurotoxicology. 2011; 
32:171–179. [PubMed: 21192973] 
Letz R, DiIorio CK, Shafer PO, Yeager KA, Schomer DL, Henry TR. Further standardization of some 
NES3 tests. Neurotoxicology. 2003; 24:491–501. [PubMed: 12900062] 
Letz, R. Neurobehav Syst. Atlanta, GA: 2000. NES3 user’s manual. 
Lucchini R, Apostoli P, Perrone C, Placidi D, Albini E, Migliorati P, et al. Long-term exposure to low 
levels of manganese oxides and neurofunctional changes in ferroalloy workers. Neurotoxicology. 
1999; 20:287–297. [PubMed: 10385891] 
Martinu K, Monchi O. Cortico-basal ganglia and cortico-cerebellar circuits in Parkinson’s disease: 
pathophysiology or compensation. Behav Neurosci. 2013; 127:222–236. [PubMed: 23244290] 
McClure P, Odin M. Exposure-response relationships for subclinical neurological effects in 
manganese-exposed workers. Syracuse Res Corp. 1998
Mergler D, Huel G, Bowler R, Iregren A, Belanger S, Baldwin M, et al. Nervous system dysfunction 
among workers with long-term exposure to manganese. Environ Res. 1994; 64:151–180. 
[PubMed: 8306949] 
Mohr B, MacGregor LJ, Difrancesco S, Harrington K, Pulvermuller F, Shtyrov Y. Hemispheric 
contributions to language reorganisation: an MEG study of neuroplasticity in chronic post stroke 
aphasia. Neuropsychologia. 2016; 93:413–424. [PubMed: 27063061] 
Myers JE, Thompson ML, Naik I, Theodorou P, Esswein E, Tassell H, et al. The utility of biological 
monitoring for manganese in ferroalloy smelter workers in South Africa. Neurotoxicology. 2003a; 
24:875–883. [PubMed: 14637382] 
Myers JE, Thompson ML, Ramushu S, Young T, Jeebhay MF, London L, et al. The nervous system 
effects of occupational exposure on workers in a South African manganese smelter. 
Neurotoxicology. 2003b; 24:885–894. [PubMed: 14637383] 
Park RM, Bowler RM, Eggerth DE, Diamond E, Spencer KJ, Smith D, et al. Issues in neurological risk 
assessment for occupational exposures: the Bay Bridge welders. Neurotoxicology. 2006; 27:373–
384. [PubMed: 16332392] 
Park RM, Bowler RM, Roels HA. Exposure-response relationship and risk assessment for cognitive 
deficits in early welding-induced manganism. J Occup Environ Med Am Coll Occup Environ Med. 
2009; 51:1125–1136.
Park RM, Baldwin M, Bouchard MF, Mergler D. Airborne manganese as dust vs: fume determining 
blood levels in workers at a manganese alloy production plant. Neurotoxicology. 2014a; 45:267–
275. [PubMed: 24726792] 
Park RM, Bouchard MF, Baldwin M, Bowler R, Mergler D. Respiratory manganese particle size, time-
course and neurobehavioral outcomes in workers at a manganese alloy production plant. 
Neurotoxicology. 2014b; 45:276–284. [PubMed: 24721790] 
Ramoju SP, Mattison DR, Milton B, McGough D, Shilnikova N, Clewell HJ, et al. The application of 
PBPK models in estimating human brain tissue manganese concentrations. Neurotoxicology. 2017; 
58:226–237. [PubMed: 27989617] 
Roels HA, Ghyselen P, Buchet JP, Ceulemans E, Lauwerys RR. Assessment of the permissible 
exposure level to manganese in workers exposed to manganese dioxide dust. Br J Ind Med. 1992; 
49:25–34. [PubMed: 1733453] 
SAS. SAS Version 9.3. SAS Institute Inc; Cary, NC: 1999. 
Thompson ML, Myers JE. Evaluating and interpreting exposure-response relationships for manganese 
and neurobehavioral outcomes. Neurotoxicology. 2006; 27:147–152. [PubMed: 16159667] 
Park and Berg Page 10
Neurotoxicology. Author manuscript; available in PMC 2018 April 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Park and Berg Page 11
Ta
bl
e 
1
R
isk
 a
ss
es
sm
en
ts 
fo
r m
an
ga
n
es
e 
an
d 
im
pa
ire
d 
ey
e-
ha
nd
 c
oo
rd
in
at
io
n,
 u
sin
g 
R
oe
ls 
et
 a
l. 
(19
92
) d
at
a,
 a
ss
um
in
g 
im
pa
irm
en
t a
t f
ift
h 
pe
rc
en
til
e 
of
 
pe
rfo
rm
an
ce
 in
 p
op
ul
at
io
n 
fo
r v
ar
io
us
 le
v
el
s o
f m
an
ga
n
es
e-
at
tr
ib
u
ta
bl
e 
ex
ce
ss
 r
isk
.
Be
nc
hm
ar
k 
D
os
e,
 μ
g/
m
3 ,
 r
es
pi
ra
bl
e 
M
n
R
isk
 In
cr
em
en
t, 
pe
r 
10
00
10
0
50
10
5
1
10
%
5%
1%
0.
5%
0.
1%
Cr
um
p 
Co
nt
in
uo
us
 O
ne
 H
it
11
3
Cr
um
p 
Co
nt
in
uo
us
 L
in
ea
r M
ea
n 
Fc
n
14
9
EP
A
 Q
ua
nta
l L
ine
ar
11
0
SR
C 
Po
ly
no
m
ia
l
16
0
81
16
8
1.
6
EP
A
 L
og
-lo
gi
sti
c
17
6
SR
C 
Lo
g-
lo
gi
sti
c
18
3
13
8
82
67
45
Cr
um
p 
Qu
an
tal
 W
ei
bu
ll
17
9
Cl
ew
el
l W
ei
bu
lla
15
5
EP
A
 W
ei
bu
ll
17
0
SR
C 
W
ei
bu
ll
17
6
11
9
49
33
14
A
bb
re
v
ia
tio
ns
: E
PA
 =
 U
.S
. E
nv
iro
nm
en
ta
l P
ro
te
ct
io
n 
A
ge
nc
y;
 F
cn
 =
 fu
nc
tio
n;
 S
RC
 =
 S
yr
ac
us
e 
Re
se
ar
ch
 C
or
po
ra
tio
n 
(M
cC
lu
re
 a
nd
 O
di
n,
 1
99
8).
a C
le
w
el
l e
t a
l. 
(20
03
). S
ou
rc
e:
 M
cC
lu
re
 a
nd
 O
di
n 
(19
98
) u
n
le
ss
 o
th
er
w
ise
 n
ot
ed
.
Neurotoxicology. Author manuscript; available in PMC 2018 April 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Park and Berg Page 12
Ta
bl
e 
2
Es
tim
at
ed
 b
en
ch
m
ar
k 
do
se
 ex
po
su
re
 le
v
el
s f
or
 a
irb
or
ne
 m
an
ga
n
es
e 
(μg
/m
3 M
n) 
in 
Ba
y B
rid
ge
 w
eld
ers
.
Po
pu
la
tio
n 
Pe
rc
en
til
e 
D
ef
in
in
g 
Im
pa
ir
m
en
t
1s
t  
pe
rc
en
til
e
5t
h  
pe
rc
en
til
e
10
th
 
pe
rc
en
til
e
B
en
ch
m
ar
k 
Ri
sk
 (p
er 
10
00
)a
1
10
50
10
0
1
10
50
10
0
1
10
50
10
0
R
el
at
iv
e 
R
isk
1.
1
2.
0
6.
0
11
1.
02
1.
2
2.
0
3.
0
1.
01
1.
1
1.
5
2.
0
W
M
I (
B;
 ha
lf-
lif
e =
 27
5 d
a)
10
51
11
0
14
4
1
12
45
72
0.
4
6
27
47
D
FT
 (B
; h
alf
-li
fe 
= 9
0 d
a)
25
67
10
8
12
9
4
27
62
84
1
14
42
61
V
IQ
 (c
um
B;
 ha
lf-
lif
e =
 40
0 d
a)
16
74
15
1
19
4
2
20
67
10
3
1
10
40
68
V
CI
 (c
um
B;
 ha
lf-
lif
e =
 40
0 d
a)
14
70
14
6
19
0
2
20
68
10
4
1
10
42
72
ST
P2
 
(cu
mB
; h
alf
-li
fe 
= ∞
)
2
19
76
12
9
1
10
45
83
0.
5
8
36
68
A
bb
re
v
ia
tio
ns
: B
 =
 M
n 
bu
rd
en
; c
um
B 
= 
cu
m
ul
at
iv
e 
M
n 
bu
rd
en
; D
FT
 =
 D
es
ig
n 
Fl
ue
nc
y;
 S
TP
 =
 S
tro
op
 C
ol
or
 W
o
rd
 T
es
t; 
V
CI
 =
 V
er
ba
l C
om
pr
eh
en
sio
n 
In
de
x
; V
IQ
 = 
Ve
rb
al
 In
te
lli
ge
nc
e 
Qu
oti
en
t; W
M
I =
 
W
o
rk
in
g 
M
em
or
y 
In
de
x
.
a R
isk
 re
su
lti
ng
 fr
om
 a
 tw
o
-y
ea
r e
x
po
su
re
, c
al
cu
la
te
d 
us
in
g 
5t
h 
pe
rc
en
til
e e
sti
m
at
ed
 fr
om
 re
gr
es
sio
n 
re
sid
ua
l s
ta
nd
ar
d 
er
ro
r.
So
ur
ce
: P
ar
k 
et
 a
l. 
(20
09
), T
ab
le
 7
.
Neurotoxicology. Author manuscript; available in PMC 2018 April 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Park and Berg Page 13
Table 3
Risk assessments from Quebec smelter and welder apprentice studies: Mn airborne concentrations 
corresponding to excess risk of impairment defined as 1.64 SD departure from population mean.
Excess risk Mn concentrations (μg/m3)
Per 1000 Quebec smelter workers Apprentice welders CPT-response time4
Luria Motor Scale1 Trail making A2 Trail making B3
200 60 28 >200 11
100 37 17 >200 6.6
50 21 10 113 3.9
20 10 4.7 25 1.9
10 5.5 2.5 7.0 1.0
5 2.8 1.3 1.9 0.5
2 1.2 0.6 0.3 0.2
1 0.6 0.3 0.1 0.1
CPT = continuous performance test (response time).
1
Park et al. (2014b) (45 yr from age 20; burden of saturation dose >= 25 with 5 yr Thalf; small respirable Mn).
2
Park et al. (2014b) (45 yr from age 20; burden of saturation dose >= 25 with 10 yr Thalf; small respirable Mn).
3
Park et al. (2014b) (45 yr from age 20; burden of sqrt of dose with 1 yr Thalf; small respirable Mn).
4
Laohaudomchok et al. (2011) (500 h/yr; 15 yr from age 20 to 35; cumulative PM 2.5 Mn).
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Table 4
Risk assessments based on 5% (or 1.64 SD) impairment definition and for 1% increase in impairment, for 
reported or cumulative effect and with 5-year equivalent steady-state.
Population (Mn sampling fraction, duration for 
calculation, n) end-point (Mn metric, half-life)
Mn exposures conferring 1% 
excess risk
Reported or 
calculated 
cum. effect 
μg/m3
For 5 year 
steady-state 
equiv.
Belgian battery factory, 1992 a (respirable, 5 yr, n = 92) Eye-hand, Polynomial (curX) 16 16
Eye-hand, Log-logistic (curX) 82 82
Eye-hand, Weibull (curX) 49 49
South African smelter, 2003 b (inhalable, 45 yr, n = 509) Santa Ana pegboard (cumX) 3.5 32
Benton visual retention (cumX) 5.8 52
Digit span (forward and back) (cumX) 6.4 58
Digit-symbol (cumX) 12 106
Reaction time (cumX) 5.4 48
Finger tapping, endurance (cumX) 7.8 70
Finger tapping, dom. (cumX) 4.4 40
Finger tapping, non-dom. (cumX) 9.5 84
Quebec alloy smelter, 2014 c (small respirable, 45 yr, n = 
106)
Luria Motor (B, 5 yr) 5.5 11
Trail Making A (B, 10 yr) 2.5 8.5
Trail Making B (B, 1 yr) 7.0 7.3
San Fran. bridge welders, 2009 d (respirable, 2 yr, n = 44) Working Memory Index (B, 275 da) 12 9.8
Design Fluency Test (B, 90 da) 6.6 6.6
Verbal Intelligence Quotient (cumB, 400 da) 14 3.5
Verbal Comprehension Index (cumB, 400 da) 13 3.2
Stroop Color Word Test, (cumB, >20 yr) 15 2.5
WAIS-III Processing Speed Index (cumX) 40 16
Digit symbol coding (cumX) 21 8.6
Trail Making A (T) (cumX) 89 35
Finger tapping, non-dom. (T) (cumX) 33 13
Grooved pegboard, non-dom. (T) (cumX) 23 9.1
Dynamometer, non-dom. (T) (cumX) 22 8.8
Santa Ana pegboard, dom. (z) (cumX) 13 5.4
Santa Ana pegboard, non-dom. (z) (cumX) 16 6.3
Apprentice welders, 2011e (PM 2.5, 15 yr, n = 46) Reaction time, CPT (cumX) 1.0 2.9
curX – current Mn exposure B – Mn burden (half-life, yr) cumB – cumulative Mn burden (half-life, yr).
cumX – cumulative Mn exposure X – Mn, respirable unless indicated otherwise T – standardized T-score.
a
McClure and Odin (1998).
b
Myers et al. (2003b) with normative data.
c
Park et al. (2014b).
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d
Park et al. (2009) (for motor outcomes (using regression results, on cumX): personal communication, V. Gocheva and R. Bowler, 10/28/16).
e
Laohaudomchok et al. (2011) (500 h/yr; from age 20 to 35).
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